Effect of resveratrol on herpesvirus encephalitis: Evidences for its mechanisms of action
Phytomedicine · 2024
DOI: 10.1016/j.phymed.2024.155476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Ziwei Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Engineering, Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou …. Hauptthemen laut MEDLINE: Encephalitis, Herpes Simplex, Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Guangdong Provincial Special Fund for Modern Agriculture Industry Technology Innovation Teams, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Herpes simplex virus type 1 (HSV-1)-induced herpes simplex encephalitis (HSE) has a high mortality rate in clinically immunocompromised patients, while recovered patients often experience neurological sequelae due to neuroinflammation. Nucleoside drugs and nucleoside analogues such as acyclovir and ganciclovir are mainly used in clinical treatment, and the emergence of resistant viral strains makes the development of new anti-herpesvirus encephalitis drugs urgent. Resveratrol is a multifunctional, plant-derived bioactive compound and its antiviral potential is attracting much attention. PURPOSE: This study aimed to investigate the anti-HSV-1 mechanism of resveratrol in microglial cells and in the HSE mouse model. METHODS: The antiviral effect of resveratrol on HSV-1 infection was investigated by plaque assay, virus titer, immunofluorescence, Western blot and time-of-addition assay. The influence of resveratrol on stimulator of interferon gene (STING)/Nuclear Factor kappa B (NF-κB) signaling pathway-mediated neuroinflammation was examined by Western blot, RT-qPCR and ELISA. The interaction between resveratrol and STING/heat shock protein 90 beta (HSP90β) was evaluated by molecular modeling, co-immunoprecipitation, and drug affinity responsive target stability assay. The therapeutic effect of resveratrol on HSE was evaluated in the HSE mouse model by analyzing weight loss, neurodegenerative symptoms and histopathological scores. RESULTS: Resveratrol inhibited the early process of HSV-1 infection, and interfered with the STING/NF-κB signaling pathway to attenuate HSV-1-induced neuroinflammation and microglial M1 polarization, independent of its classical target Sirtuin1. Mechanistically, resveratrol completely bound to Glu515 and Lys491 of HSP90β, thus disrupting the HSP90β-STING interaction and promoting STING degradation. Resveratrol also significantly alleviated viral encephalitis and neuroinflammation caused by HSV-1 in the HSE mouse model. CONCLUSION: Resveratrol acted as a non-classical HSP90β inhibitor, binding to the STING-HSP90β interaction site to promote STING degradation and attenuate HSV-1-induced encephalitis and neuroinflammation. These findings suggest the alternative strategy of targeting HSP90β and resveratrol-mediated inhibition of HSP90β as a potential antiviral approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Engineering, Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Institute of Biomedicine, Guangdong Province Key Laboratory of Bioengineering Medicine, Key Laboratory of innovative technology research on natural products and cosmetics raw materials, College of Life Science and Techn…
- Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China; Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou 510632, China.
- Department of Pharmacy, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, China.
- Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hos…
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China. Electronic address: zhengk@szu.edu.cn.
Förderung
- Guangdong Provincial Special Fund for Modern Agriculture Industry Technology Innovation Teams
- National Natural Science Foundation of China
Zitieren
APA
Huang, Z., Li, S., Zhong, L., Su, Y., Li, M., Wang, X., Wang, Z., Wang, Z., Ye, C., Ren, Z., Wang, X., Zeng, Q., Zheng, K., & Wang, Y. (2024). Effect of resveratrol on herpesvirus encephalitis: Evidences for its mechanisms of action. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155476
Vancouver
Huang Z, Li S, Zhong L, Su Y, Li M, Wang X, et al. Effect of resveratrol on herpesvirus encephalitis: Evidences for its mechanisms of action. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155476
BibTeX
@article{Huang2024,
author = {Huang, Ziwei and Li, Shan and Zhong, Lishan and Su, Yuan and Li, Menghe and Wang, Xiaohui and Wang, Zexu and Wang, Zhiping and Ye, Cuifang and Ren, Zhe and Wang, Xiao and Zeng, Qiongzhen and Zheng, Kai and Wang, Yifei},
title = {Effect of resveratrol on herpesvirus encephalitis: Evidences for its mechanisms of action},
journal = {Phytomedicine},
year = {2024},
doi = {10.1016/j.phymed.2024.155476}
}
EUVIMED